Molecular Docking Software Market Set to Register a CAGR of 16.50% During the Forecast Period, Growth Plus Reports Study

Newark, New Castle, USA, March 27, 2023 (GLOBE NEWSWIRE) — According to a recent study by Growth Plus Reports, the Global Molecular Docking Software Market is expected to register a revenue CAGR of 7.5% by 2031 during the forecast period from 2023 to 2031. The study discusses the most effective tactics, market trends, major drivers and opportunities, the competitive landscape, market size, statistical statistics, and revenue.

Market Drivers: 
The growing number of people suffering from chronic long-term ailments like diabetes, Alzheimer’s, and cancer drive revenue growth in the molecular docking market. Furthermore, governments in many developing countries support using bioinformatics for rapid pharmaceutical research, contributing to the rising revenue share. However, the higher expense of this software is likely to hinder the market revenue expansion to some extent. 

Request a Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/molecular-docking-software-market/8454

                            Molecular Docking Software Market Scope

Market Segmentation:
Growth plus reports have analyzed the global molecular docking software market from product, application, end user, and region. 

Product Segmentation: 
Based on products, the global molecular docking software is segmented into software and services. 

The software segment will likely dominate the market with the largest revenue share during the forecast period. This rising revenue share is attributed to the assistance of numerous molecular design processes, including chemical structure calculations, protein simulations, and other operations in drug design and bioinformatics. 

Application Segmentation: 
Based on application, the global molecular docking software is segmented into drug discovery and drug development. 

The drug discovery segment is expected to dominate the market revenue during the forecast period. Molecular docking in drug development predicts the binding of a small molecule to a protein target to study the effectiveness of a drug, thus contributing enormously to the molecular docking market revenue rise.   

End-user Segmentation: 
Based on the end users, the molecular docking software has been segmented into pharmaceuticals & biotechnology companies and research & academic institutes. 
Research & academic institutes are expected to account for the largest revenue share in the market during the forecast period. This rising revenue share is due to the increasing number of research and studies to investigate the new proteins and ligand interaction. 

Regional Growth Dynamics:
Based on region, the molecular docking software is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa. 

North America accounts for the largest market revenue share and is expected to dominate continuously during the forecast period. This rising revenue share is attributed to the prevalence of chronic diseases and increasing demand for better modeling tools to investigate disease prevalence to create effective therapies. 

Asia Pacific is expected to rise significantly in molecular docking software market revenue during the forecast period. This rise is due to the increasing number of contract research firms (especially in countries like India and Singapore).

Request for Customization –  https://www.growthplusreports.com/inquiry/customization/molecular-docking-software-market/8454

Competitive Landscape:

The key players operating in the global molecular docking software include: 

• Chemical Computing Group
• Schrodinger, Inc.
• OpenEye Scientific Software
• BioSolveIT GmbH 
• Optibrium
• Scripps Research Institute 
• Cresset
• GSSSB
• DNASTAR

To thrive through strategic alliances, companies must form strategic alliances and merge with or acquire other enterprises. By ‘pooling the funds’ of the partnership’s enterprises, they can boost the overall monetary resources available for research and development to produce better, more effective, and safer treatments in lesser time. 

Recent Developments:

• In November 2022, AutoDock, Surflex-Dock, rDock, and Discovery Studios are four molecular docking software tools published by CD ComputaBio to help in virtual screening and drug discovery initiatives. 
• In March 2022, ChemDraw V21, released by PerkinElmer, Inc., a global company devoted to designing a healthier world, offers to import, animate, and share 3D chemical structures natively in the Microsoft PowerPoint software with a single click.

Table of Content

1. INTRODUCTION
   1. Market Ecosystem
   2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
   3. Currency Used in the Report
2. RESEARCH METHODOLOGY 
   1. Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
   4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
   5. Market Forecasting Model
   6. Limitations and Assumptions
3. PREMIUM INSIGHTS
   1. Current Market Trends (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2022)
   3. Regulatory Landscape
4. MARKET DYNAMICS
   1. Drivers
   2. Restraints/Challenges
   3. Opportunities
5. GLOBAL MOLECULAR DOCKING SOFTWARE MARKET – ANALYSIS & FORECAST, BY PRODUCT
   1. Software 
   2. Services
6. GLOBAL MOLECULAR DOCKING SOFTWARE MARKET – ANALYSIS & FORECAST, BY APPLICATION
   1. Drug Discovery
   2. Drug Development
   3. Others
7. GLOBAL MOLECULAR DOCKING SOFTWARE MARKET – ANALYSIS & FORECAST, BY END USER
   1. Pharmaceuticals & Biotechnology Companies 
   2. Research & Academic Institutes 
   3. Other

TOC Continued…

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8454

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• ‘Business Profile’ of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at – https://www.growthplusreports.com/report-store

Browse related reports:

Hyaluronic Acid Products Market by Application (Dermal Fillers, Osteoarthritis), End-user (Personal Care Industry, Pharmaceutical Industry) – Global Outlook & Forecast 2023-2031

In-vitro Diagnostics Standards and Controls Market by Product & Services (Quality Control Products, Data Management Solutions), Application (Clinical Chemistry, Immunochemistry, Hematology) Manufacturer Type (Third Party Control, Original Equipment Manufacturer Control) End User (Home Care, Laboratory) – Global Outlook & Forecast 2023-2031

Medical Device Outsourcing Market by Service (Quality Assurance, Regulatory Affairs Services), Class Type (class I, class II), Application (Cardiology, Diagnostic Imaging) – Global Outlook & Forecast 2023-2031

NGS Sample Preparation Market by Product & Services (Instruments, Reagents & Consumables), Workflow (DNA Fragmentation & Library Preparation), Sample Type (DNA, RNA), Application (Disease Diagnostics, Drug Diagnostics), End User (Hospitals & Clinics, Academics Institutes & Research Centers) – Global Outlook & Forecast 2023-2031

Plasma Fractionation Market by Product (Immunoglobulin), Application (Neurology, Hematology), End-user (Hospitals & Clinics) – Global Outlook & Forecast 2023-2031

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.